The private shareholders of Cutter Associates, LLC have sold the company to Nomura Research Institute (NRI) for an undisclosed consideration.
Cutter Associates is the leading global provider of independent, proprietary research, business consulting and IT services to the world’s preeminent buy-side investment managers.
NRI is a leading provider of consulting service and system solutions, founded in 1965. Headquartered in Tokyo, Japan, NRI’s services include management and system consulting, system integration, IT management, and IT solutions for the financial, manufacturing, and service industries. Leveraging its global consulting business, NRI is able to provide innovative, cross-asset and financial IT solutions for investment banks, asset managers, banks and insurance providers.
One of Oaklins' teams in the USA advised the seller in this transaction. The team assisted Cutter in identifying, attracting and consummating a transaction with NRI, a world-class strategic partner which will provide significant resources and global reach to enable Cutter’s management team to leverage synergies created by the transaction and accelerate growth.
Tom Seeman, CEO at Cutter Associates, LLC, said: "We engaged the specialist team as our investment banker based on the firm’s strong reputation in the market and its IT industry experience. We immediately noticed the team's seniorlevel commitment to our transaction, and also the quality of its associates and analysts. They delivered as promised and architected a great outcome with a world-class buyer who, we believe, will create meaningful opportunities for our employees and clients. I was particularly impressed with the team’s experience in navigating the complexities of a cross-border transaction, in this case with a Japanese buyer. That expertise proved critical to the success of this transaction."
© Oaklins, alle Rechte vorbehalten. Oaklins bezieht sich auf Oaklins International Inc. und/oder eines seiner Mitgliedsunternehmen, die jeweils eine eigene Rechtsperson sind. Weitere Informationen finden Sie unter www.oaklins.com/legal.